Long-term incobotulinumtoxinA treatment for chronic sialorrhea: Efficacy and safety over 64 weeks
نویسندگان
چکیده
منابع مشابه
Long-term safety and efficacy data on botulinum toxin type A: an injection for sialorrhea.
OBJECTIVE To evaluate the safety and efficacy data on salivary gland injection botulinum toxin type A for the treatment of sialorrhea. DESIGN AND SETTING Retrospective cohort study in a tertiary academic children's hospital. PATIENTS A 10-year review (January 1, 2001, through December 31, 2010) of 69 children with sialorrhea who had undergone salivary gland injection of botulinum toxin type...
متن کاملLong-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia
INTRODUCTION Previously, controlled trials have demonstrated the efficacy and tolerability of fixed doses of incobotulinumtoxinA (Xeomin, NT 201, botulinum toxin type A free from complexing proteins) to treat cervical dystonia (CD). To explore the clinical relevance of these findings, this study evaluated long-term use of flexible dosing regimens of incobotulinumtoxinA in a setting close to rea...
متن کاملPeripheral Nerve Stimulation for the Treatment of Chronic Intractable Headaches: Long-term Efficacy and Safety Study.
BACKGROUND Despite the various modalities available for treating headaches, typical therapy does not provide adequate pain relief for some patients. OBJECTIVES This study explored the efficacy and safety of long-term peripheral nerve stimulation (PNS) for intractable chronic headaches. STUDY DESIGN Retrospective study of refractory headache patients at academic pain center. METHODS The me...
متن کاملAlemtuzumab treatment of multiple sclerosis: long-term safety and efficacy.
OBJECTIVES Alemtuzumab is a newly licensed treatment of active relapsing-remitting multiple sclerosis (RRMS) in Europe, which in phase II and III studies demonstrated superior efficacy over β-interferon in reducing disability progression over 2-3 years. In this observational cohort study, we sought to describe our longer-term experience of the efficacy and safety of alemtuzumab in active RRMS. ...
متن کاملSafety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP.
Chronic immune thrombocytopenic purpura (ITP) is characterized by low platelet counts and mucocutaneous bleeding. In previous studies romiplostim (AMG531), a thrombopoiesis-stimulating protein, increased platelet counts in most patients with chronic ITP. This ongoing, long-term open-label, single-arm study investigated safety and efficacy in patients who completed a previous romiplostim study a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Parkinsonism & Related Disorders
سال: 2020
ISSN: 1353-8020
DOI: 10.1016/j.parkreldis.2019.11.024